Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27781294 | 0.96 | TSHR (0.40) | TSHRLMNATHRBFDPSTDP1 | |
| SCHEMBL7091661 | 0.93 | TSHR (0.44) | TSHRLMNATHRBFDPSTDP1 | |
| SCHEMBL598961 | 0.93 | TSHR (0.38) | TSHRLMNATHRBFDPSTDP1 | |
| SCHEMBL9833392 | 0.90 | TSHR (0.50) | TSHRTHRBFDPSTDP1FFAR1 | |
| SCHEMBL27796954 | 0.90 | TSHR (0.50) | TSHRTHRBFDPSTDP1FFAR1 | |
| SCHEMBL8897161 | 0.90 | TSHR (0.50) | TSHRTHRBFDPSTDP1FFAR1 | |
| SCHEMBL27348149 | 0.90 | TSHR (0.50) | TSHRTHRBFDPSTDP1FFAR1 | |
| SCHEMBL6063824 | 0.89 | TSHR (0.47) | TSHRLMNATHRBFDPSTDP1 | |
| SCHEMBL8159115 | 0.86 | TSHR (0.53) | TSHRTHRBFDPSTDP1FFAR1 | |
| SCHEMBL20856453 | 0.86 | TSHR (0.53) | TSHRTHRBFDPSTDP1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11462305-B2 | Biomarkers for detecting colorectal cancer or adenoma and methods thereof | Precogify Pharmaceutical China Co., Ltd. (CN) | 2022-10-04 | — | — | US | disclosed |
| US-20220108777-A1 | BIOMARKERS FOR DETECTING COLORECTAL CANCER OR ADENOMA AND METHODS THEREOF | Precogify Pharmaceutical China Co., Ltd. (CN) | 2022-04-07 | — | — | US | disclosed |
| US-20200171214-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2020-06-04 | — | — | US | disclosed |
| EP-3648806-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | Drei Lilien PVG GmbH & Co. KG (DE) | 2020-05-13 | — | — | EP | disclosed |
| EP-3601444-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | BASF Coatings GmbH (DE) | 2020-02-05 | — | — | EP | disclosed |
| WO-2019008192-A1 | BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION | DREI LILIEN PVG GMBH & CO. KG (DE) | 2019-01-10 | — | — | WO | disclosed |
| WO-2018177731-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | BASF COATINGS GMBH (DE) | 2018-10-04 | — | — | WO | disclosed |
| US-9975831-B2 | Method for producing ether compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-05-22 | — | — | US | disclosed |
| WO-2017116540-A9 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-08-17 | — | — | WO | disclosed |
| WO-2017116540-A1 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-07-06 | — | — | WO | disclosed |
| US-20150011799-A1 | METHOD FOR PRODUCING ETHER COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2813482-A1 | METHOD FOR PRODUCING ETHER COMPOUND | Takasago International Corporation (JP) | 2014-12-17 | — | — | EP | disclosed |
| CN-102482225-A | Process for preparing 1-phenylpyrazoles | BASF SE | 2012-05-30 | — | — | CN | disclosed |
| CN-102325747-A | Process for preparing 2-aminobiphenylene compounds | BASF SE | 2012-01-18 | — | — | CN | disclosed |
| EP-0531715-B1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL CO (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011799-A1 | METHOD FOR PRODUCING ETHER COMPOUND | CBR3, CYP2E1, HPD | TSHR 4272/4885LMNA 4037/4885THRB 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.